News | Nuclear Imaging | March 21, 2019

Improving Molecular Imaging Using a Deep Learning Approach

New technique has the potential to improve the quality and speed of imaging

Improving Molecular Imaging Using a Deep Learning Approach

March 21, 2019  — Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed using a new deep learning approach to image reconstruction developed by researchers at Rensselaer Polytechnic Institute.

The research team’s new technique has the potential to vastly improve the quality and speed of imaging in live subjects and was the focus of an article recently published in Light: Science and Applications, a Nature journal.1

Compressed sensing-based imaging is a signal processing technique that can be used to create images based on a limited set of point measurements. Recently, a Rensselaer research team proposed a novel instrumental approach to leverage this methodology to acquire comprehensive molecular data sets, as reported in Nature Photonics.2 While that approach produced more complete images, processing the data and forming an image could take hours.

This latest methodology developed at Rensselaer builds on the previous advancement and has the potential to produce real-time images, while also improving the quality and usefulness of the images produced. This could facilitate the development of personalized drugs, improve clinical diagnostics or identify tissue to be excised.

In addition to providing an overall snapshot of the subject being examined, including the organs or tumors that researchers have visually targeted with the help of fluorescence, this imaging process can reveal information about the successful intracellular delivery of drugs by measuring the decay rate of the fluorescence.

To enable almost real-time visualization of molecular events, the research team has leveraged the latest developments in artificial intelligence. The vastly improved image reconstruction is accomplished using a deep learning approach. Deep learning is a complex set of algorithms designed to teach a computer to recognize and classify data. Specifically, this team developed a convolutional neural network architecture that the Rensselaer researchers call Net-FLICS (fluorescence lifetime imaging with compressed sensing).

“This technique is very promising in getting a more accurate diagnosis and treatment,” said Pingkun Yan, co-director of the Biomedical Imaging Center at Rensselaer. “This technology can help a doctor better visualize where a tumor is and its exact size. They can then precisely cut off the tumor instead of cutting a larger part and spare the healthy, normal tissue.”

Yan developed this approach with corresponding author Xavier Intes, the other co-director of the Biomedical Imaging Center at Rensselaer, which is part of the Rensselaer Center for Biotechnology and Interdisciplinary Studies. Doctoral students Marien Ochoa and Ruoyang Yao supported the research.

“At the end, the goal is to translate these to a clinical setting. Usually when you have clinical systems you want to be as fast as possible,” said Ochoa, as she reflected on the speed with which this new technique allows researchers to capture these images.

Further development is required before this new technology can be used in a clinical setting. However, its progress has been accelerated by incorporating simulated data based on modeling, a particular specialty for Intes and his lab.

“For deep learning usually you need a very large amount of data for training, but for this system we don’t have that luxury yet because it’s a very new system,” said Yan.

He said that the team’s research also shows that modeling can innovatively be used in imaging, accurately extending the model to the real experimental data.

For more information: www.nature.com/lsa

 

References

1. Yao R., Ochoa M., Yan P., Intes X. Net-FLICS: fast quantitative wide-field fluorescence lifetime imaging with compressed sensing – a deep learning approach. Light: Science and Applications, March 6, 2019. https://doi.org/10.1038/s41377-019-0138-x

2. Pian Q., Yao R., Sinsuebphon N., Intes X. Compressive hyperspectral time-resolved wide-field fluorescence lifetime imaging. Nature Photonics, June 5, 2017.

Related Content

Konica Minolta Business Solutions, U.S.A., Inc. (Konica Minolta) announced its status as a Google Cloud Premier Partner.
News | Archive Cloud Storage | January 14, 2020
January 14, 2020 — ...
Videos | RSNA | January 13, 2020
ITN Editor Dave Fornell takes a tour of some of the most innovative new medical imaging technologies displayed on the
This is artificial intelligence on Fujifilm's mobile digital radiography system to immediately detect pneumothorax (a collapsed lung) and show the location to the technologist and attending physician in a unit before the image is even uploaded to the PACS for a read. AI applications like this that have immediate impact on critical patient care saw a lot of interest at RSNA 2019.

This is work-in-progress artificial intelligence app on Fujifilm's mobile digital radiography system to immediately detect pneumothorax (a collapsed lung), The AI highlights the area of interest to show the location to the technologist and attending physician in a unit before the image is even uploaded to the PACS for a read by a radiologist. The technology also can flag the study for an immediate read in the PACS worklist for confirmation by a human. This technology is from a third-party and will be offered on Fujifilm's REiLI AI platform. Applications like this that have immediate impact on critical patient care saw a lot of interest at RSNA 2019. Photos by ITN Editor Dave Fornell.

Feature | Artificial Intelligence | December 27, 2019 | Siddharth Shah and Srikanth Kompalli, Frost & Sullivan
Radiology artificial intelligence (AI) was again the hottest topic at the 2019...
News | Remote Viewing Systems | December 27, 2019
December 27, 2019 — The Radiological Society of North America (RSNA) and Carequality have developed the Imaging Data
Feinstein Institutes' Thomas Chaly, Ph.D., poses in front of a PET-CT imaging machine. He has been instrumental in pushing for FDA approval of a new PET imaging agent, Fluorodopa F-18 (FDOPA), to combat Parkinson’s

Feinstein Institutes' Thomas Chaly, Ph.D., in front of a PET-CT imaging machine. He has been instrumental in pushing for FDA approval of a new PET imaging agent, Fluorodopa F-18 (FDOPA), to combat Parkinson’s

News | Nuclear Imaging | December 26, 2019
December 26, 2019 — The Feinstein Institutes for Medical R...
The Radiological Society of North America (RSNA) presented its eighth Alexander R. Margulis Award for Scientific Excellence to Jae Ho Sohn, M.D., from the Radiology & Biomedical Imaging Department at the University of California in San Francisco (UCSF)

Jae Ho Sohn, M.D.

News | RSNA | December 24, 2019
December 24, 2019 — The Radiological Society of North America (R